AstraZeneca’s experimental drug for a rare autoimmune disorder helped patients control their disease, the company says, boosting prospects for the potential blockbuster medicine https://t.co/EXIc325yfT ...

Roche’s experimental drug for a deadly lung condition got mixed results in trials, a setback as the company seeks to accelerate the development of new treatments https://t.co/08IlVIVFXg ...

AstraZeneca’s experimental drug for a rare plasma cell disorder failed to delay deaths or reduce hospitalizations, dimming hopes for treating severe cases https://t.co/GmXb2u6u4I ...